Meet our team
Mikael Totterman, Chairman
Before founding Clerio Vision, Mike served as the Chief Innovation Officer of iCardiac Technologies.
Prior to that he also was Chairman and CEO of iCardiac, a leading provider of cardiac safety testing services to the global pharmaceutical R&D industry. Mike co-founded iCardiac in 2008 with Alex Zapesochny and Sasha Latypova as a with technology licensed from the University of Rochester. The company was backed by several venture and angel investors.
Mike also has been the Chief Operating Officer and Acting CEO of VirtualScopics Inc., now part of BioTelemetry Research, a leading developer of image-based biomarkers for improving pharmaceutical development. During his tenure at VirtualScopics, he lead several of rounds of venture capital funding as well as striking strategicinvestment relationships with Pfizer, Inc. and GE Healthcare.
Earlier in his career, Mike also served as a principal at 3Com Ventures, a $250 million venture capital fund based in Santa Clara, CA as well as building 3Com’s Network of Global Strategic Alliances with company’s including Philips, Siemens, AT&T and British Telecom. He has also held positions at Boston Consulting Group as well as Gemini Consulting.
Mike received his Bachelor’s Degree in Engineering from Stanford University where he was a David Starr Jordan Scholar and his Masters of Business Administration from the Amos Tuck School at Dartmouth College.
Alex Zapesochny, CEO
Alex is an experienced technology executive and attorney who previously served as Executive Vice President of Cardiac Safety at ERT.
A co-founder of iCardiac Technologies, Alex served as its President and CEO until ERT acquired the company in late 2017. He founded iCardiac with Mike Totterman and Sasha Latypova.
Prior to joining iCardiac, Alex was General Counsel and Director of Business Development for Lenel Systems International, a developer and global supplier of high-end software, products and services for the security industry.
Alex was part of a small executive management team that guided the company to extraordinary growth. The company expanded to serving over 10,000 organizations throughout 75 countries, including security-conscious entities such as Microsoft, Cisco, all three New York City-area airports, the Department of Homeland Security and over 60 percent of all Fortune 100 companies. The company’s financial growth earned it 39th place on Inc. magazine’s ranking of the nation’s fastest-growing privately-held companies, and Lenel was acquired for $440 million by United Technologies Corporation (NYSE: UTX) in March 2005.Alex remained with UTC after the acquisition and continued in his legal and business development roles within the Lenel Systems subsidiary.
Alex, who is known for interest in entrepreneurial activity, provides legal and business counsel to early-stage companies. He has been a trial attorney during his tenure as a New York City prosecutor, a policy division staff member in the Washington headquarters of a presidential campaign, and Co-Founder and Executive Director of an award-winning non-profit that expands the national registry of potential bone marrow and blood stem cell donors.
Alex received his undergraduate degree from Cornell University and graduate degrees from American University, University of Oxford and the University of Cambridge.
Jay Baker, Chief Financial Officer
Jay served as Chief Financial Officer for iCardiac Technologies from the founding of the company in 2006 to its sale to ERT in 2017.
He was responsible for all finance and human resources operations of the company. Jay also oversaw iCardiac’s logistical operations which supported thousands of clinical trial sites globally.
Before joining the team at iCardiac, Jay served as Controller at Lenel Systems. He worked at Lenel from 1996, when the company had less than $1 million in revenues, up until its sale in 2005 to UTC. By then Lenel had reached $100 million in run-rate revenues.